• DSHS HIV/STD Program

    Post Office Box 149347, MC 1873
    Austin, Texas 78714

    Phone: 737-255-4300

    Email the HIV/STD Program

    Email HIV, STD, Hepatitis C, and TB data requests to the Program – This email can be used to request data and statistics on HIV, STDs, Hepatitis C, and TB in Texas. It cannot be used to get treatment or infection history for individuals, or to request information on programs and services. Please do not include any personal, identifying health information in your email such as HIV status, Date of Birth, Social Security Number, etc.

    For treatment/testing history, please contact your local health department.

    For information on HIV testing and services available to persons living with HIV, please contact your local HIV services organization.

220.101

Purchasing Prescription or Over-the-Counter Medications and Vitamins Not Covered by a Third-Party Payor

Policy
Policy Number 220.101
Effective Date March 25, 1998
Revision Date May 1, 2000
Approval Authority TB/HIV/STD Section Director

1.0 Purpose

This policy provides guidance on the appropriate use of grant funds to purchase over-the-counter (OTC) medication when clients are not eligible for prescription medication services provided through third-party payors. Contracting agencies will be able to purchase prescription medication for clients: 1) who do not have or are not eligible for insurance, 2) when a prescription medication is not allowed under certain third-party payor criteria, and 3) to meet medication needs that are not met by other sources of funding. This policy is directed to contracting agencies providing HIV-related public health services whose activities allow for medication purchases (i.e., Ryan White Title II, state services, and early intervention programs). Application of this policy will assure that grant funds reimburse for medication only when no other parties will pay.

 

2.0 Authority

Ryan White CARE Act Amendments of 1996, Section 2616; Texas Dangerous Drug Act, V.T.C.A. Health and Safety Code, Chapter 483; Texas Administrative Code, Section 291.33, Class A Pharmacy Operational Standards; Texas Administrative Code, Section 291.93, Class D Pharmacy Operational Standards; Code of Federal Regulations, Title 21, Section 310.518, Drug Products Containing Iron or Iron Salts; HIV/STD Policy No. 220.100; HIV/STD Policy No. 540.001.

 

3.0 Program Requirements

The Texas Department of State Health Services (DSHS) requires a consortium considering medication purchases to develop a formulary or designate a dollar amount per client based on client needs and budgeting caps. To assure the best use of grant funds, the need for medication purchases must be identified prior to budgeting. As with all budgeting, allocations are based upon needs identified in the local needs assessment.

When the need for a formulary has been identified, the DSHS requires that the consortium form a three-member committee to be responsible for developing a formulary and budget. The committee must consist of a physician, pharmacist, and the executive director of the administrative agency. A nurse practitioner or physician’s assistant who is working with the physician may represent the physician on the committee. Should the consortium be unable to fulfill the committee member requirements, substitutes must be approved by the HIV/STD Prevention and Care Branch of the TB/HIV/STD Section.

It is the responsibility of the committee to decide the extent to which they will use the grant funds, which are set aside by the consortium, to purchase medication for eligible clients. The consortium should approve the final formulary and budget prior to implementing, however, the consortium may not make any changes to the final formulary submitted by the committee.

 

4.0 Client Eligibilities

Clients who qualify for prescription medication services provided through third-party payors such as health insurance, Medicaid, the HIV/STD Medication Program, indigent health care, or the HIV Health Options to Promote Employment (HOPE) Program are not eligible to receive services directed through this policy. Purchasing of medication listed on the HIV/STD Medication Program formulary for clients eligible to receive third-party reimbursable services is covered under the provisions of HIV/STD Policy No. 220.100. Clients unable to meet co-pay requirements should request assistance through their local Ryan White Insurance Program or apply to the HIV HOPE Program administered by the DSHS.

When a purchase of a prescription medication is not allowed under certain third-party payor criteria and the client is without means to pay for the prescription medication, the client is eligible to receive prescription medication services, provided funds are available. To receive assistance, the client must provide documentation to the contracting agency that the third-party payor does not cover the requested medication.

 

5.0 Prescription Medication

Only licensed practitioners (i.e., pharmacists, physicians, nurses, dentists, and podiatrists) may dispense prescription medication. Prescription medication may not be budgeted as food pantry purchases. Agencies may purchase medication through the HIV/STD Medication Program (Medication Plus Program). For more information regarding the Medication Plus Program, contact the HIV/STD Medication Program at 1-800-255-1090. Another alternative for purchasing medication is to establish a cost reimbursement system with pharmacies licensed to distribute medications in Texas. Funds may not be used to make direct payments of cash to a client.

Employees, board members, clients, or volunteers of an agency are restricted from collecting and/or dispensing prescriptions, or prescription medication except when working under the provision of a license issued by the Texas State Board of Pharmacy. Agencies that stock, collect, or dispense any prescription medication without physician orders or who interfere with the legal dispensing of prescription medications will be in violation of this policy and be subject to contract termination. Violations of State pharmaceutical laws will be reported to the proper authorities.

 

6.0 Over-the-Counter Medication and Vitamins

Facilities may provide OTC medication only when the medication is approved by the Food and Drug Administration (FDA), sealed by the manufacturer, and not past the expiration date. Vitamins may be provided when they are sealed by the manufacturer. These items should be stored in a restricted, non-client flow area, which is locked when unattended. Vitamins containing iron must have a child-proof cap. No partially used or opened containers may be passed on to others. Employees and volunteers who are not licensed practitioners of facilities that stock vitamins and OTC medication should not physically hand these items out to clients. Under these circumstances, clients should be allowed to choose and remove vitamins and OTC medication from the shelf themselves. Clinicians may provide OTC medication and vitamins with appropriate client consultation and education.

Facilities providing OTC medication and/or vitamins will post appropriate bilingual signs stating at least the following:

“Please talk with your doctor, nurse, or pharmacist about possible side effects before taking any over-the-counter medication or vitamin.”

 

7.0 Clinical Trials

HIV service funds awarded through DSHS may not be used to support the costs of operating clinical trials of investigational agents or treatments (to include administrative management or medical monitoring of patients). Funds may, however, be used to promote enrollment in clinical trials as part of broader outreach activities or to support clinical costs of expanded access or compassionate use programs where efficacy data exist and where the FDA has authorized such expanded use.

Expanded Access Programs - created by the FDA for the purpose of making promising new treatments available to persons with life-threatening diseases and with no other treatment options.

Compassionate Use Programs - programs sponsored by pharmaceutical companies to make investigational new medications available for the same group of persons described in expanded access programs.

 

8.0 Compliance Monitoring

The HIV/STD Prevention and Care Branch and Field Operations Branch staff will work together to verify compliance of this policy during site visits. Contracting agencies that violate this policy will face administrative sanctions, up to and including termination of their contract. Refer to HIV/STD Policy No. 540.001 for information relating to sanctions imposed upon contractors for noncompliance.

 

9.0 Revision History

Date Action Section
Revision History
9/1/2017 Changed "TB/HIV/STD Unit" to "TB/HIV/STD Section" to reflect new program designation -
9/25/2014 Converted format (Word to HTML) -
11/13/2002 Converted format (WordPerfect to Work) -

 


Last updated June 15, 2020